Skip to main content
. 2010 Mar 18;4:31–37. doi: 10.4137/cmc.s4472

Table 2.

Echocardiographic findings in control (n = 38) and thalassemia patients (n = 38) in the study population. Data are presented as mean ± SEM per body surface area (m2). P value < 0.05 is considered statistically significant.

Parameter Control Thalassemia P-value
IVS/BSA (cm/M2) 0.446 ± 0.219 0.659 ± 0.26 <0.001*
PW/BSA (cm/M2) 0.437 ± 0.214 0.659 ± 0.235 <0.001*
LVEDD/BSA (mm/M2) 2.170 ± 0.57 3.995 ± 0.48 <0.035*
LVESD/BSA (mm/M2) 2.217 ± 0.45 2.40 ± 0.54 <0.001*
FS (%) 31.329 ± 3.810 33.878 ± 4.944 0.107
LVEF (%) 57.656 ± 6.641 58.454 ± 6.504 0.103
E wave/BSA (cm/sec) 57.532 ± 12.959 70.818 ± 10.139 <0.027*
A wave/BSA (cm/sec) 46.330 ± 9.851 44.646 ± 7.776 0.109
E/A ratio 1.233 ± 0.27 1.54 ± 0.235 <0.021
DT/BSA (msec) 167.123 ± 19.143 150.234 ± 20.023 <0.01
IVRT/BSA (msec) 75.474 ± 5.83 60.647 ± 6.770 <0.01
Tricuspid velocity/BSA (m/sec) 1.453 ± 0.471 2.993 ± 0.569 <0.01

Abbreviations: IVS, interventricular septal thickness; Pw, posterior wall thickness; LVEDD, left ventricle end diastolic diameter; LVESD, left ventricle end systolic diameter; FS, fractional shortening; EF, left ventricle ejection fraction; E wave, mitral E wave peak velocity; A wave, mitral A wave peak velocity; DT, E wave deceleration time; IVRT, isovolumic relaxation time; TR, tricuspid velocity.